Figure 2From: Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient populationSymptomatic remission achievement in the risperidone (long-acting, injectable) (RLAI) group according to International Classification of Diseases , 10th edition (ICD-10) diagnosis (analysis of covariance (ANCOVA)).Back to article page